# PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients

> **NCT01856595** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 117 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** PF-06291874
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01856595
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-13
- **Primary completion:** 2014-01-10
- **Final completion:** 2014-03-01
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2018-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01856595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01856595, "PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01856595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*